Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite
- PMID: 9780195
Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite
Abstract
Immunization with DNA vaccines encoding relevant Ags can induce not only cell-mediated immune response but also humoral immune responses against pathogenic microorganisms in several animal models. Our previous results demonstrated that, when the C terminus (PyC2) of Plasmodium yoelii merozoite surface protein-1 (MSP-1), a leading vaccine candidate against erythrocytic stages of malaria, was expressed as a fusion protein (GST-PyC2) with glutathione S-transferase (GST), it elicited Ab-mediated protective immune responses in BALB/c mice. In our present study, we wished to examine the humoral responses to a DNA vaccine (V3) encoding GST-PyC2. The GST-PyC2 expressed in V3-transfected Cos 7 cells was recognized by a protective monoclonal Ab to PyC2 (mAb302), although the secreted product had undergone N-linked glycosylation. When BALB/c mice were immunized with V3 plasmid, anti-PyC2 Abs were successfully induced. These Abs immunoprecipitated native PyMSP-1 protein and competed with mAb302 for binding to its epitope at a level similar to those elicited by GST-PyC2 protein immunization. However, these Abs had significantly lower titers and avidities, and different isotype profiles and protective capacities against a lethal erythrocytic stage challenge, than those resulting from immunization with GST-PyC2 protein. Most surprising was the finding that, in contrast to protein immunization, there was no significant increase in the avidity of either GST-specific or PyC2-specific IgG Abs during the course of DNA immunization. This suggests that there may be little or no affinity maturation of specific Abs during DNA immunization in this system.
Similar articles
-
Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.Exp Parasitol. 1999 Jan;91(1):78-85. doi: 10.1006/expr.1999.4357. Exp Parasitol. 1999. PMID: 9920045
-
Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.J Immunol. 1998 Aug 15;161(4):1908-12. J Immunol. 1998. PMID: 9712060
-
Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.Clin Vaccine Immunol. 2007 Apr;14(4):342-7. doi: 10.1128/CVI.00397-06. Epub 2007 Feb 21. Clin Vaccine Immunol. 2007. PMID: 17314232 Free PMC article.
-
Immunological responses of neonates and infants to DNA vaccines.Methods Mol Med. 2006;127:239-51. doi: 10.1385/1-59745-168-1:239. Methods Mol Med. 2006. PMID: 16988458 Review.
-
DNA vaccines against malaria: immunogenicity and protection in a rodent model.J Pharm Sci. 1996 Dec;85(12):1294-300. doi: 10.1021/js960147h. J Pharm Sci. 1996. PMID: 8961142 Review.
Cited by
-
Co-infection of malaria and gamma-herpesvirus: exacerbated lung inflammation or cross-protection depends on the stage of viral infection.Clin Exp Immunol. 2004 Dec;138(3):396-404. doi: 10.1111/j.1365-2249.2004.02652.x. Clin Exp Immunol. 2004. PMID: 15544614 Free PMC article.
-
Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.Infect Immun. 2002 Nov;70(11):6075-82. doi: 10.1128/IAI.70.11.6075-6082.2002. Infect Immun. 2002. PMID: 12379684 Free PMC article.
-
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.Infect Immun. 2001 May;69(5):3041-7. doi: 10.1128/IAI.69.5.3041-3047.2001. Infect Immun. 2001. PMID: 11292722 Free PMC article.
-
Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.Vaccine. 2010 Jul 19;28(32):5280-7. doi: 10.1016/j.vaccine.2010.05.054. Epub 2010 Jun 4. Vaccine. 2010. PMID: 20562015 Free PMC article.
-
Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate.Vaccine. 2010 Mar 19;28(14):2580-92. doi: 10.1016/j.vaccine.2010.01.019. Epub 2010 Jan 22. Vaccine. 2010. PMID: 20097151 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials